Search Results - "Pietrasz, D"

Adjuvant chemotherapy in patients with resected pancreatic cancer following neoadjuvant FOLFIRINOX chemotherapy: an international multicenter study by Van Roessel, S., Van Veldhuisen, E., Jansen, K., Abu Hilal, M., Alseidi, A., Bassi, C., Malleo, G., Del Chiaro, M., Hackert, T., Falconi, M., Mortensen, M., Lesurtel, M., Keck, T., Pietrasz, D., Strobel, O., Tarvainen, T., Van Laarhoven, H., Wilmink, H., Groot Koerkamp, B., Besselink, M.

Get full text

Faut-il réaliser une chimiothérapie adjuvante systématique pour un cancer du rectum supposé T3N+ en préopératoire, finalement T3N0 à l’examen sur pièce après exérèse totale du mésorectum ? by Pietrasz, D., Lefevre, J. -H.

Get full text

Combined Anterior and Superior Approach to Superior Mesenteric Artery (SMA) during Pancreaticoduodenectomy by Pittau, G., Pietrasz, D., Cunha, A. Sa

Get full text

Intraoperative hyperspectral imaging to predict thrombotic complications in pancreatic transplantation by Peloso, A., Ciacio, O., Pittau, G., Salloum, C., Pietrasz, D., Sa Cunha, A., Golse, N.

Get full text

Superior Mesenteric Artery First Approach: A Safe Technique to Achieve Better Oncological Results after Pancreaticoduodenectomy for Cancer by Pittau, G., Beghdadi, N., Pietrasz, D., Romano, P., Ciacio, O., Salloum, C., Lewine, M., Ulusakarya, A., Cherqui, D., Hammel, P., Cunha, A. Sa

Get full text

Evaluation of Adjuvant Chemotherapy in Patients With Resected Pancreatic Cancer After Neoadjuvant FOLFIRINOX Treatment by van Roessel, Stijn, van Veldhuisen, Eran, Klompmaker, Sjors, Janssen, Quisette P, Abu Hilal, Mohammed, Alseidi, Adnan, Balduzzi, Alberto, Balzano, Gianpaolo, Bassi, Claudio, Berrevoet, Frederik, Bonds, Morgan, Busch, Olivier R, Butturini, Giovanni, Del Chiaro, Marco, Conlon, Kevin C, Falconi, Massimo, Frigerio, Isabella, Fusai, Giuseppe K, Gagnière, Johan, Griffin, Oonagh, Hackert, Thilo, Halimi, Asif, Klaiber, Ulla, Labori, Knut J, Malleo, Giuseppe, Marino, Marco V, Mortensen, Michael B, Nikov, Andrej, Lesurtel, Mickaël, Keck, Tobias, Kleeff, Jörg, Pandé, Rupaly, Pfeiffer, Per, Pietrasz, D, Roberts, Keith J, Sa Cunha, Antonio, Salvia, Roberto, Strobel, Oliver, Tarvainen, Timo, Bossuyt, Patrick M, van Laarhoven, Hanneke W M, Wilmink, Johanna W, Groot Koerkamp, Bas, Besselink, Marc G

“…The benefit of adjuvant chemotherapy after resection of pancreatic cancer following neoadjuvant combination treatment with folinic acid, fluorouracil,…”
Get more information

The value of adjuvant chemotherapy in patients after resection of pancreatic adenocarcinoma following preoperative FOLFIRINOX: an international multicenter study by Stoop, T.F., Sugawara, T., Oba, A., Feld, I.M., Alseidi, A., Kokkola, A., Koerkamp, B. Groot, Pietrasz, D., Kleive, D.B., Frigerio, I., Gagnière, J., Ramia, J.M., Kleeff, J., Roberts, K.J., Marino, M.V., Falconi, M., Pfeiffer, P., Salvia, R., Dokmak, S., Hackert, T., Messersmith, W., Wilmink, J.W., Burkhart, R., Del Chiaro, M., Besselink, M.G.

Get full text

623PPlasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer by Moati, E, Blons, H, Taly, V, Garlan, F, Shu-Fang, W-R, Pietrasz, D, Didelot, A, Garrigou, S, Saint, A, Pernot, S, Taieb, J, Laurent-Puig, P, Zaanan, A

“…Abstract Background In metastatic colorectal cancer (mCRC), circulating tumour DNA (ctDNA) monitoring can be used to genotype tumors and track clonal…”
Get full text

Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer by Moati, E., Blons, H., Taly, V., Garlan, F., Shu-Fang, W.-R., Pietrasz, D., Didelot, A., Garrigou, S., Saint, A., Pernot, S., Taieb, J., Laurent-Puig, P., Zaanan, A.

Get full text

623P - Plasma clearance of RAS mutation under therapeutic pressure is a rare event in metastatic colorectal cancer by Moati, E., Blons, H., Taly, V., Garlan, F., Shu-Fang, W.-R., Pietrasz, D., Didelot, A., Garrigou, S., Saint, A., Pernot, S., Taieb, J., Laurent-Puig, P., Zaanan, A.

“…In metastatic colorectal cancer (mCRC), circulating tumour DNA (ctDNA) monitoring can be used to genotype tumors and track clonal evolution. We investigated…”
Get full text

Surgical and Oncological Outcomes After Preoperative FOLFIRINOX Chemotherapy in Resected Pancreatic Cancer: An International Multicenter Cohort Study by van Veldhuisen, Eran, Klompmaker, Sjors, Janssen, Quisette P., Hilal, Mohammed Abu, Alseidi, Adnan, Balduzzi, Alberto, Balzano, Gianpaolo, Bassi, Claudio, Berrevoet, Frederik, Bonds, Morgan, Busch, Olivier R., Butturini, Giovanni, Conlon, Kevin C., Frigerio, Isabella M., Fusai, Giuseppe K., Gagnière, Johan, Griffin, Oonagh, Hackert, Thilo, Halimi, Asif, Keck, Tobias, Kleeff, Jörg, Klaiber, Ulla, Labori, Knut J., Lesurtel, Mickael, Malleo, Giuseppe, Marino, Marco V., Molenaar, I. Quintus, Mortensen, Michael B., Nikov, Andrej, Pagnanelli, Michele, Pandé, Rupaly, Pfeiffer, Per, Pietrasz, Daniel, Rangelova, Elena, Roberts, Keith J., Cunha, Antonio Sa, Salvia, Roberto, Strobel, Oliver, Tarvainen, Timo, Wilmink, Johanna W., Koerkamp, Bas Groot, Besselink, Marc G.

“…Background Preoperative FOLFIRINOX chemotherapy is increasingly administered to patients with borderline resectable (BRPC) and locally advanced pancreatic…”
Get full text

Short term outcomes of minimally invasive donor hepatectomy: A European experience by Halim, N Abdul, Pittau, G., Sa cunha, A., Ciacio, O., Pietrasz, D., Castaing, D., Vibert, E., Adam, R., Cherqui, D.

Get full text

Evaluation of a micro-spectrometer for the real-time assessment of liver graft with mild-to-moderate macrosteatosis: A proof of concept study by Golse, Nicolas, Cosse, Cyril, Allard, Marc-Antoine, Laurenzi, Andrea, Tedeschi, Michele, Guglielmo, Nicola, Fernandez-Sevilla, Elena, Robert, Maud, Tréchot, Boris, Pietrasz, Daniel, Pittau, Gabriella, Ciacio, Oriana, Sa Cunha, Antonio, Castaing, Denis, Cherqui, Daniel, Adam, René, Samuel, Didier, Sebagh, Mylene, Vibert, Eric

“…[Display omitted] •Liver macrosteatosis is a major prognostic factor after liver transplantation.•Visual estimation is inaccurate and frozen sections are…”
Get full text

Outcome of patients with pancreatic adenocarcinoma with complete pathological response following neo-adjuvant therapy by Kourie, H.R., Sa Cunha, A., Pernot, S., Coriat, R., Sauvanet, A., Regenet, N., Louafi, S., Bachet, J-B., Pietrasz, D., Taieb, J.

Get full text

Risk factors for severe morbidity and definitive stoma after elective surgery for sigmoid diverticulitis: a multicenter national cohort study by Sabbagh, C., Beyer-Berjot, L., Ouaissi, M., Zerbib, P., Bridoux, V., Manceau, G., Karoui, M., Panis, Y., Buscail, E., Venara, A., Khaoudy, I., Gaillard, M., Ortega-Deballon, P., Viennet, M., Thobie, A., Menahem, B., Eveno, C., Bonnel, C., Mabrut, J.-Y., Badic, B., Godet, C., Eid, Y., Duchalais, E., Lakkis, Z., Cotte, E., Laforest, A., Defourneaux, V., Maggiorri, L., Rebibo, L., Christou, N., Talal, A., Mege, D., Bonnamy, C., Germain, A., Mauvais, F., Tresallet, C., Ahmed, O., Regimbeau, J.-M., Roudie, J., Laurent, A., Trilling, B., Bertrand, M., Massalou, D., Romain, B., Tranchart, H., Giger, U., Dejardin, O., Pellegrin, A., Alves, A.

“…Background In the decision to perform elective surgery, it is of great interest to have data about the outcomes of surgery to individualize patients who could…”
Get full text

Preoperative chemoradiotherapy after induction FOLFIRINOX improve R0 resection margins rate and histological response in patients secondary resected in borderline or locally advanced pancreatic adenocarcinoma by Pietrasz, D., Turrini, O., Vendrely, V., Laurent, C., Terrebonne, E., Hentic Dhome, O., Sauvanet, A., Simon, J-M., Coriat, R., Portales, F., Le Roy, B., Pointet, A-L., Marthey, L., Regenet, N., Goere, D., Artru, P., Vaillant, J-C., Delpero, J-R., Bachet, J-B., Sa Cunha, A.

Get full text